MedPath
NMPA Approval

黄体酮

国药准字H11021732

August 16, 2020

国药准字H11021732

Drug Information

黄体酮

原料药

化学药品

August 16, 2020

Company Information

Applicant Company

Manufacturing Company

河北省秦皇岛市经济技术开发区龙海道10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

黄体酮 - NMPA 批准文号 | MedPath